Your browser doesn't support javascript.
loading
Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor model.
Hartmann, Laura; Osen, Wolfram; Eichmüller, Oliver L; Kordaß, Theresa; Furkel, Jennifer; Dickes, Elke; Reid, Carissa; Debus, Jürgen; Brons, Stephan; Abdollahi, Amir; Moustafa, Mahmoud; Rieken, Stefan; Eichmüller, Stefan B.
Afiliação
  • Hartmann L; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Osen W; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Eichmüller OL; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany; Institute of Molecular Biotechnology (IMBA), Austrian Academy of Sciences, Vienna Biocenter (VBC), Vienna, Austria.
  • Kordaß T; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Furkel J; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center, Heidelberg, Germany; CCU Translational Radiation Oncology, German Cancer Consortium (DKTK) Core-Center Heidelberg, He
  • Dickes E; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Reid C; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Debus J; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center, Heidelberg, Germany; CCU Translational Radiation Oncology, German Cancer Consortium (DKTK) Core-Center Heidelberg, Heidelberg University Hospital (UKHD) and German Cancer Research Cente
  • Brons S; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Heidelberg, Germany.
  • Abdollahi A; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center, Heidelberg, Germany; CCU Translational Radiation Oncology, German Cancer Consortium (DKTK) Core-Center Heidelberg, Heidelberg University Hospital (UKHD) and German Cancer Research Cente
  • Moustafa M; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center, Heidelberg, Germany; CCU Translational Radiation Oncology, German Cancer Consortium (DKTK) Core-Center Heidelberg, Heidelberg University Hospital (UKHD) and German Cancer Research Cente
  • Rieken S; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center, Heidelberg, Germany; CCU Translational Radiation Oncology, German Cancer Consortium (DKTK) Core-Center Heidelberg, Heidelberg University Hospital (UKHD) and German Cancer Research Cente
  • Eichmüller SB; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: s.eichmueller@dkfz.de.
Cancer Lett ; 550: 215928, 2022 12 01.
Article em En | MEDLINE | ID: mdl-36183858
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia com Íons Pesados / Inibidores de Checkpoint Imunológico Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia com Íons Pesados / Inibidores de Checkpoint Imunológico Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article